Nasdaq rxrx
Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Add to Watchlist. Add to Portfolio. RXRX RXRX AFTER HOURS QUOTE RXRX LATEST AFTER HOURS TRADES. Find the latest Institutional Holdings data for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) at Nasdaq.com. Recursion Pharmaceuticals (NASDAQ: RXRX) exploded in July on the strength of hot news—a $50 million direct investment from Nvidia (NASDAQ: NVDA). Since that month’s high, shares are back in ...
Did you know?
Shares of RXRX rallied more than 75% on Wednesday, July 12. At one point, the stock traded as high as $14.99, up 121% on the day. Now trading above that level — and up in five of the last six ...12 Tem 2023 ... On today's stock market, Recursion shares skyrocketed 78.2% and closed at 12.08. Before the stock market opened, RXRX stock had catapulted more ...Coinbase Global Inc (NASDAQ:COIN) Zymergen Inc (NASDAQ:ZY) Signify Health Inc (NYSE:SGFY) Repare Therapeutics Inc (NASDAQ:RPTX) Recursion Pharmaceuticals Inc (NASDAQ:RXRX) 908 Devices Inc (NASDAQ ...Recursion Pharmaceuticals, Inc. is a clinical-stage TechBio biotechnology company. It is focused on utilizing advanced technologies in biology, chemistry, …SALT LAKE CITY, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery, today reported business updates and financial results for its fourth quarter and fiscal year ending December 31, 2022.12 Tem 2023 ... Confirming the ongoing fervor for all things artificial intelligence (AI), shares of biotechnology firm Recursion Pharmaceuticals (NASDAQ:RXRX) ...NASDAQ: RXRX Recursion Pharmaceuticals. Market Cap. $2B. Today's Change (7.88%) $0.54 ... (RXRX 7.88%) and CRISPR Therapeutics, (CRSP 2.88%) two of the most followed biotechs this year. Both ...15 Kas 2023 ... Graphic designer/iStock via Getty Images. AI-driven drug discovery firm Recursion Pharmaceuticals (NASDAQ:RXRX) added ~17% on Wednesday ...For a biotech like Recursion Pharmaceuticals (NASDAQ: RXRX) that aims to use artificial intelligence (AI) and petabytes of data as tools for drug discovery and development, computing power is a ...— Recursion (Nasdaq : RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry ...Overview News Recursion Pharmaceuticals Inc. No significant news for in the past two years. Key Stock Data N/A EPS (TTM) $-1.47 $1.48 B ) Shares Sold Short 35.50 M Change from Last 7.40% Percent...AI-driven drug discovery firm Recursion Pharmaceuticals (NASDAQ:RXRX) added ~17% on Wednesday after ARK Innovation ETF (NYSEARCA:ARKK), managed by famous stock picker Cathie Wood, bought ~3.8M of ...RXRX Recursion Pharmaceuticals Inc Bayer and Recursion Focus Research Collaboration on Oncology. Berlin, Germany and Salt Lake City, USA, Nov. 09, 2023 (GLOBE NEWSWIRE) ...Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) Add to Watchlist. Add to Portfolio. Nov 24, 2023 · See the latest Recursion Pharmaceuticals Inc Class A stock price (RXRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Nov 28, 2023 · Recursion Pharmaceuticals Inc (NASDAQ:RXRX) trade information. Instantly RXRX has showed a red trend with a performance of -4.81% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 7.23 on Monday, 11/27/23 increased the stock’s daily price by 9.68%. 15 Kas 2023 ... Graphic designer/iStock via Getty Images. AI-driven drug discovery firm Recursion Pharmaceuticals (NASDAQ:RXRX) added ~17% on Wednesday ...Nov 9, 2023 · About RecursionRecursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a ... (NASDAQ:RXRX), which I spoke about on Aug. 8. At the time, Nvidia (NASDAQ:NVDA) had just investing $50 million in the company to help it create new AI models, and software to create new drug ...Recursion Pharmaceuticals (NASDAQ:RXRX) has witnessed quite a roller-coaster year. A resounding investment of $50 million from tech titan Nvidia (NASDAQ:NVDA) in July rocketed its shares.Nov 22, 2023 · That's what's happeniSALT LAKE CITY, Dec. 6, 2021 /PRNewswire/ -- Recursion (NA RXRX Latest Real Time Trades ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, and more asset classes. /Nov 26, 2023 · NASDAQ: RXRX Recursion Pharmaceuticals. Market Cap. $2B. Today's Change (0.43%) $0.03. Current Price. $7.05. ... (RXRX 0.43%) that aims to use artificial intelligence (AI) and petabytes of data as ... 4. Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) Recursion Ph Shares of Recursion Pharmaceuticals (RXRX 4.89%) were skyrocketing 82% higher this week as of the market close on Thursday, according to data provided by S&P Global Market Intelligence.Jul 13, 2023 · In recent trading, shares of Recursion Pharmaceuticals Inc (Symbol: RXRX) have crossed above the average analyst 12-month target price of $11.29, changing hands for $12.02/share. When a stock ... The average one-year price target for Recursion Pharmaceuti
Nov 30, 2023 · Financial Performance. In 2022, RXRX's revenue was $39.84 million, an increase of 291.46% compared to the previous year's $10.18 million. Losses were -$239.48 million, 28.4% more than in 2021. Financial Statements. Microsoft Corporation Common Stock. $376.39 +0.22 +0.06%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers ... MarketWatch IBD Sign In Recursion Pharmaceuticals Inc. RXRX (U.S.: Nasdaq) Overview News Recursion Pharmaceuticals Inc. No significant news for in the …... NASDAQ. Market Closed. RECURSION PHARMACEUTICALS INC (RXRX). 6.86 0.08 (1.18%) +0.08 (+1.18%) 0.08 (1.18%). As of 24 November 2023 02:00 PM EST. Currency USD.2,015.20 +2.80(+0.14%) Advertisement Recursion Pharmaceuticals, Inc. (RXRX) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 6.53 -0.33 (-4.81%) At close: 04:00PM EST 6.65...
JPMorgan Trims Price Target on Recursion Pharmaceuticals to $10 From $11, Maintains Neutral Rating. Nov. 13. MT. Needham Adjusts Recursion Pharmaceuticals Price Target to $15 From $17, Maintains Buy Rating. Nov. 10. MT. Recursion Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September …Find the latest Institutional Holdings data for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) at Nasdaq.com. …
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Recursion Pharmaceuticals (NASDAQ:RXRX) stock pop. Possible cause: 9 Kas 2023 ... ... (NASDAQ: RXRX), a leading clinical stage techbio com.
Recursion Pharmaceuticals Inc (NASDAQ: RXRX)’s stock price has increased by 1.33 compared to its previous closing price of 6.78. However, the company has seen a 3.00% increase in its stock price over the last five trading sessions. The Motley Fool reported 2023-11-26 that Nvidia will help Recursion build a massive supercomputer. This will be used […]Recursion Pharmaceuticals Inc. Class A (RXRX) Share Price. NASDAQ. $7.05. As on 17-Nov-2023 16:06 EST. up-down-arrow $0.38 • 5.70%. 1D 1M 3M 1Y All Custom. Prev ...
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, ...Recursion Pharmaceuticals (NASDAQ: RXRX) has witnessed quite a roller-coaster year. A resounding investment of $50 million from tech titan Nvidia (NASDAQ: NVDA) in July rocketed its shares.
On July 21, Recursion Pharmaceuticals, Inc. (NASD Recursion Pharmaceuticals has a market capitalisation of US$1.9b and burnt through US$113m last year, which is 6.0% of the company's market value. Given that is a rather small percentage, it would ...Find the latest Insider Activity data for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) at Nasdaq.com. It has been a tumultuous year for the clFind the latest on short interest for Rec Well, Nvidia (NASDAQ:NVDA) just invested $50 million to “boost Recursion’s drug-discovery companies.” Prior to today’s announcement, RXRX stock sat in negative territory for the year.12 Tem 2023 ... Confirming the ongoing fervor for all things artificial intelligence (AI), shares of biotechnology firm Recursion Pharmaceuticals (NASDAQ:RXRX) ... Recursion Pharmaceuticals Inc (NASDAQ:RXRX) trade information Recursion (NASDAQ: RXRX) is a clinical-stage biotechnology company. It develops drugs for a variety of diseases, including Alzheimer's, cancer, and rare diseases. The company was founded in 2013 and is based in Salt Lake City, Utah.Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. Recursion Pharmaceuticals, Inc. Class A Common SFind the latest Insider Activity data for Recursion (NASDAQ:RXRX), which I spoke about on Aug. 8. At the time, Nvidia ( Jan 12, 2022 · So should Recursion Pharmaceuticals (NASDAQ:RXRX) shareholders be worried about its cash burn? In this article, we define cash burn as its annual (negative) free cash flow, which is the amount of ... 30 Haz 2021 ... ... (Nasdaq: ABCL), Recursion Pharmaceuticals (Nasdaq: RXRX), Zymergen (Nasdaq: ZY), Desktop Metal (NYSE: DM) and Lucira Health (Nasdaq: LHDX). Nov 30, 2023 · Recursion Pharmaceuticals (NASDAQ:RXRX) and Mirum Or, we can look back at Recursion Pharmaceuticals. (NASDAQ:RXRX), which I spoke about on Aug. 8.At the time, Nvidia (NASDAQ:NVDA) had just investing $50 million in the company to help it create ...Track Recursion Pharmaceuticals Inc - Ordinary Shares - Class A (RXRX) Stock Price, Quote, latest community messages, chart, news and other stock related ... Recursion Pharmaceuticals Inc (NASDAQ:RXRX). 7.[Or, we can look back at Recursion PharmaceutiIt has been a tumultuous year for the clini Find the latest Earnings Report Date for Recursion Pharmaceuticals, Inc. Class A Common Stock (RXRX) at Nasdaq.com.The Dow Jones Industrial Average paced gains with a jump of nearly 1.5%, or more than 500 points, reaching a new closing high for 2023. The S&P 500 popped nearly 0.4%, reversing earlier losses ...